Gerresheimer: in early talks with private-equity suitors
Published by Global Banking & Finance Review®
Posted on February 7, 2025
1 min readLast updated: January 26, 2026

Published by Global Banking & Finance Review®
Posted on February 7, 2025
1 min readLast updated: January 26, 2026

Gerresheimer is in early talks with private equity investors for a potential sale, with interest from Warburg Pincus, EQT AB, and KKR.
(Reuters) -German medical packaging maker Gerresheimer on Friday said it was in early-stage discussions with private equity investors over a potential sale of the company, adding that it would evaluate any offers in the best interest of the company.
Earlier on Friday, Bloomberg News report said the company was working with advisers to gauge interest from possible buyers, adding that Warburg Pincus, EQT AB and KKR are among suitors that have been studying the business. Its shares jumped as much as 15% after the news.
"Such discussions are still in a very preliminary stage. It is not foreseeable at this point in time whether a public takeover offer will actually be made," the company said in a statement.
Activist investor Ricky Chad Sandler had bought a 5.43% stake in the German medical packaging maker in October 2024.
(Reporting by Devika Nair in Bengaluru and Riham Alkoussa in Berlin; Editing by Devika Syamnath and Ludwig Burger)
The main topic is Gerresheimer's early-stage discussions with private equity investors regarding a potential sale.
Potential buyers include Warburg Pincus, EQT AB, and KKR.
Gerresheimer's shares increased by 15% after the news broke.
Explore more articles in the Finance category




